Log in to your Inderes Free account to see all free content on this page.
Pharma Equity Group
0.09 DKK
-4.28 %
Less than 1K followers
PEG
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Dividend
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Pharma Equity Group
P/E
Median 2020-2025
P/B
Median 2020-2025
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Share price (DKK) | 0.47 | 0.28 | 0.46 | 0.43 | 0.19 | 0.09 |
| Shares | 31.1 | 55.6 | 37.3 | 1,023.0 | 1,227.6 | 1,227.5 |
| Market cap | 14.6 | 15.6 | 17.1 | 439.9 | 233.2 | 114.7 |
| Enterprise value | 23.1 | 33.9 | 38.2 | 458.0 | 240.0 | - |
| EV/S | - | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | 2.9 | 4.8 | neg. | neg. | neg. |
| P/B | 0.43 | 0.37 | 0.37 | 11.30 | 4.77 | 4.50 |
| P/S | - | - | - | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 59.5 % | 66.9 % | 64.8 % | 47.9 % | 74.5 % | 65.5 % |
| Gearing ratio | 24.7 % | 43.0 % | 46.3 % | 57.5 % | 22.6 % | 31.6 % |
Login required
This content is only available for logged in users